Seminars in Nephrology
Volume 29, Issue 3 , Pages 196-215 , May 2009

The Brain in Hyponatremia: Both Culprit and Victim

  • David B. Mount, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to David B. Mount, MD, Renal Division, Brigham and Women's Hospital, Room 540, 4 Blackfan Circle, Boston, MA 02115

References 

  1. McKenna K, Thompson C. Osmoregulation in clinical disorders of thirst appreciation. Clin Endocrinol (Oxf). 1998;49:139–152
  2. Verbalis JG, Berl T. Disorders of water balance. In:  Brenner BM editors. The Kidney. 8th ed.. Philadelphia: Saunders; 2008;p. 459–546
  3. Bourque CW. Central mechanisms of osmosensation and systemic osmoregulation. Nat Rev Neurosci. 2008;9:519–531
  4. McKinley MJ, Cairns MJ, Denton DA, et al. Physiological and pathophysiological influences on thirst. Physiol Behav. 2004;81:795–803
  5. Pasantes-Morales H, Lezama RA, Ramos-Mandujano G, Tuz KL. Mechanisms of cell volume regulation in hypo-osmolality. Am J Med. 2006;119:S4–S11
  6. Ayus JC, Achinger SG, Arieff A. Brain cell volume regulation in hyponatremia: role of sex, age, vasopressin, and hypoxia. Am J Physiol Renal Physiol. 2008;295:F619–F624
  7. Baylis PH. Osmoregulation and control of vasopressin secretion in healthy humans. Am J Physiol. 1987;253:R671–R678
  8. Robertson GL, Aycinena P, Zerbe RL. Neurogenic disorders of osmoregulation. Am J Med. 1982;72:339–353
  9. Uretsky BF, Verbalis JG, Generalovich T, Valdes A, Reddy PS. Plasma vasopressin response to osmotic and hemodynamic stimuli in heart failure. Am J Physiol. 1985;248:H396–H402
  10. Stachenfeld NS, Splenser AE, Calzone WL, Taylor MP, Keefe DL. Sex differences in osmotic regulation of AVP and renal sodium handling. J Appl Physiol. 2001;91:1893–1901
  11. Davison JM, Gilmore EA, Durr J, Robertson GL, Lindheimer MD. Altered osmotic thresholds for vasopressin secretion and thirst in human pregnancy. Am J Physiol. 1984;246:F105–F109
  12. Sladek CD, Somponpun SJ. Estrogen receptors: their roles in regulation of vasopressin release for maintenance of fluid and electrolyte homeostasis. Front Neuroendocrinol. 2008;29:114–127
  13. Miller MA, DeVries GJ, al-Shamma HA, Dorsa DM. Decline of vasopressin immunoreactivity and mRNA levels in the bed nucleus of the stria terminalis following castration. J Neurosci. 1992;12:2881–2887
  14. Pak TR, Chung WC, Hinds LR, Handa RJ. Estrogen receptor-beta mediates dihydrotestosterone-induced stimulation of the arginine vasopressin promoter in neuronal cells. Endocrinology. 2007;148:3371–3382
  15. Ikeda Y, Tanaka I, Oki Y, et al. Testosterone normalizes plasma vasopressin response to osmotic stimuli in men with hypogonadism. Endocr J. 1993;40:387–392
  16. Calzone WL, Silva C, Keefe DL, Stachenfeld NS. Progesterone does not alter osmotic regulation of AVP. Am J Physiol Regul Integr Comp Physiol. 2001;281:R2011–R2020
  17. Somponpun SJ, Sladek CD. Osmotic regulation of estrogen receptor-beta in rat vasopressin and oxytocin neurons. J Neurosci. 2003;23:4261–4269
  18. Somponpun SJ, Sladek CD. Depletion of oestrogen receptor-beta expression in magnocellular arginine vasopressin neurones by hypovolaemia and dehydration. J Neuroendocrinol. 2004;16:544–549
  19. Robertson GL. Abnormalities of thirst regulation. Kidney Int. 1984;25:460–469
  20. Fitzsimons JT. Angiotensin, thirst, and sodium appetite. Physiol Rev. 1998;78:583–686
  21. Sakai K, Agassandian K, Morimoto S, et al. Local production of angiotensin II in the subfornical organ causes elevated drinking. J Clin Invest. 2007;117:1088–1095
  22. Kong J, Zhang Z, Li D, et al. Loss of vitamin D receptor produces polyuria by increasing thirst. J Am Soc Nephrol. 2008;19:2396–2405
  23. Yuan W, Pan W, Kong J, et al. 1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem. 2007;282:29821–29830
  24. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110:229–238
  25. Lazartigues E, Sinnayah P, Augoyard G, Gharib C, Johnson AK, Davisson RL. Enhanced water and salt intake in transgenic mice with brain-restricted overexpression of angiotensin (AT1) receptors. Am J Physiol Regul Integr Comp Physiol. 2008;295:R1539–R1545
  26. McKinley MJ, Walker LL, Alexiou T, et al. Osmoregulatory fluid intake but not hypovolemic thirst is intact in mice lacking angiotensin. Am J Physiol Regul Integr Comp Physiol. 2008;294:R1533–R1543
  27. Phillips PA, Rolls BJ, Ledingham JG, Morton JJ, Forsling ML. Angiotensin II-induced thirst and vasopressin release in man. Clin Sci (Lond). 1985;68:669–674
  28. Oldenburg B, MacDonald GJ, Shelley S. Controlled trial of enalapril in patients with chronic fluid overload undergoing dialysis. Br Med J (Clin Res Ed). 1988;296:1089–1091
  29. Yamamoto T, Shimizu M, Morioka M, Kitano M, Wakabayashi H, Aizawa N. Role of angiotensin II in the pathogenesis of hyperdipsia in chronic renal failure. JAMA. 1986;256:604–608
  30. Graziani G, Badalamenti S, Del Bo A, et al. Abnormal hemodynamics and elevated angiotensin II plasma levels in polydipsic patients on regular hemodialysis treatment. Kidney Int. 1993;44:107–114
  31. Izzedine H, Fardet L, Launay-Vacher V, Dorent R, Petitclerc T, Deray G. Angiotensin-converting enzyme inhibitor-induced syndrome of inappropriate secretion of antidiuretic hormone: case report and review of the literature. Clin Pharmacol Ther. 2002;71:503–507
  32. Arinzon ZH, Lehman YA, Fidelman ZG. Cilazapril-induced SIADH. J Am Geriatr Soc. 2001;49:1735
  33. Shaikh ZH, Taylor HC, Maroo PV, Llerena LA. Syndrome of inappropriate antidiuretic hormone secretion associated with lisinopril. Ann Pharmacother. 2000;34:176–179
  34. Al-Mufti HI, Arieff AI. Captopril-induced hyponatremia with irreversible neurologic damage. Am J Med. 1985;79:769–771
  35. Lehr D, Goldman HW, Casner P. Renin-angiotensin role in thirst: paradoxical enhancement of drinking by angiotensin converting enzyme inhibitor. Science. 1973;182:1031–1034
  36. Cadnapaphornchai MA, Rogachev B, Summer SN, et al. Evidence for bradykinin as a stimulator of thirst. Am J Physiol Renal Physiol. 2004;286:F875–F880
  37. Smith D, Moore K, Tormey W, Baylis PH, Thompson CJ. Downward resetting of the osmotic threshold for thirst in patients with SIADH. Am J Physiol Endocrinol Metab. 2004;287:E1019–E1023
  38. Verney EB. The antidiuretic hormone and the factors which determine its release. Proc R Soc Lond B Biol Sci. 1947;135:25–106
  39. McKinley MJ, Denton DA, Oldfield BJ, De Oliveira LB, Mathai ML. Water intake and the neural correlates of the consciousness of thirst. Semin Nephrol. 2006;26:249–257
  40. Bourque CW, Ciura S, Trudel E, Stachniak TJ, Sharif-Naeini R. Neurophysiological characterisation of osmosensitive neurons. Exp Physiol. 2007;92:499–505
  41. Sewards TV, Sewards MA. The awareness of thirst: proposed neural correlates. Conscious Cogn. 2000;9:463–487
  42. Oliet SH, Bourque CW. Mechanosensitive channels transduce osmosensitivity in supraoptic neurons. Nature. 1993;364:341–343
  43. McKinley MJ, Mathai ML, McAllen RM, et al. Vasopressin secretion: osmotic and hormonal regulation by the lamina terminalis. J Neuroendocrinol. 2004;16:340–347
  44. McKinley MJ, Mathai ML, Pennington G, Rundgren M, Vivas L. Effect of individual or combined ablation of the nuclear groups of the lamina terminalis on water drinking in sheep. Am J Physiol. 1999;276:R673–R683
  45. Egan G, Silk T, Zamarripa F, et al. Neural correlates of the emergence of consciousness of thirst. Proc Natl Acad Sci U S A. 2003;100:15241–15246
  46. Baylis PH, Thompson CJ. Osmoregulation of vasopressin secretion and thirst in health and disease. Clin Endocrinol (Oxf). 1988;29:549–576
  47. Hamamura M, Nunez DJ, Leng G, Emson PC, Kiyama H. c-fos may code for a common transcription factor within the hypothalamic neural circuits involved in osmoregulation. Brain Res. 1992;572:42–51
  48. Shi P, Martinez MA, Calderon AS, Chen Q, Cunningham JT, Toney GM. Intra-carotid hyperosmotic stimulation increases Fos staining in forebrain organum vasculosum laminae terminalis neurones that project to the hypothalamic paraventricular nucleus. J Physiol. 2008;586:5231–5245
  49. Ciura S, Bourque CW. Transient receptor potential vanilloid 1 is required for intrinsic osmoreception in organum vasculosum lamina terminalis neurons and for normal thirst responses to systemic hyperosmolality. J Neurosci. 2006;26:9069–9075
  50. Anderson JW, Washburn DL, Ferguson AV. Intrinsic osmosensitivity of subfornical organ neurons. Neuroscience. 2000;100:539–547
  51. Qiu DL, Shirasaka T, Chu CP, et al. Effect of hypertonic saline on rat hypothalamic paraventricular nucleus magnocellular neurons in vitro. Neurosci Lett. 2004;355:117–120
  52. Zhang Z, Bourque CW. Osmometry in osmosensory neurons. Nat Neurosci. 2003;6:1021–1022
  53. Zhang Z, Bourque CW. Calcium permeability and flux through osmosensory transduction channels of isolated rat supraoptic nucleus neurons. Eur J Neurosci. 2006;23:1491–1500
  54. Oliet SH, Bourque CW. Gadolinium uncouples mechanical detection and osmoreceptor potential in supraoptic neurons. Neuron. 1996;16:175–181
  55. Colbert HA, Smith TL, Bargmann CI. OSM-9, a novel protein with structural similarity to channels, is required for olfaction, mechanosensation, and olfactory adaptation in Caenorhabditis elegans. J Neurosci. 1997;17:8259–8269
  56. Liedtke W, Choe Y, Marti-Renom MA, et al. Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor. Cell. 2000;103:525–535
  57. Mizuno A, Matsumoto N, Imai M, Suzuki M. Impaired osmotic sensation in mice lacking TRPV4. Am J Physiol Cell Physiol. 2003;285:C96–C101
  58. Strotmann R, Harteneck C, Nunnenmacher K, Schultz G, Plant TD. OTRPC4, a nonselective cation channel that confers sensitivity to extracellular osmolarity. Nat Cell Biol. 2000;2:695–702
  59. Liedtke W, Tobin DM, Bargmann CI, Friedman JM. Mammalian TRPV4 (VR-OAC) directs behavioral responses to osmotic and mechanical stimuli in Caenorhabditis elegans. Proc Natl Acad Sci U S A. 2003;100(Suppl 2):14531–14536
  60. Liedtke W, Friedman JM. Abnormal osmotic regulation in trpv4−/− mice. Proc Natl Acad Sci U S A. 2003;100:13698–13703
  61. Tsushima H, Mori M. Antidipsogenic effects of a TRPV4 agonist, 4alpha-phorbol 12,13-didecanoate, injected into the cerebroventricle. Am J Physiol Regul Integr Comp Physiol. 2006;290:R1736–R1741
  62. Sharif Naeini R, Witty MF, Seguela P, Bourque CW. An N-terminal variant of Trpv1 channel is required for osmosensory transduction. Nat Neurosci. 2006;9:93–98
  63. Suzuki M, Sato J, Kutsuwada K, Ooki G, Imai M. Cloning of a stretch-inhibitable nonselective cation channel. J Biol Chem. 1999;274:6330–6335
  64. Taylor AC, McCarthy JJ, Stocker SD. Mice lacking the transient receptor vanilloid potential 1 channel display normal thirst responses and central Fos activation to hypernatremia. Am J Physiol Regul Integr Comp Physiol. 2008;294:R1285–R1293
  65. Wainwright A, Rutter AR, Seabrook GR, Reilly K, Oliver KR. Discrete expression of TRPV2 within the hypothalamo-neurohypophysial system: implications for regulatory activity within the hypothalamic-pituitary-adrenal axis. J Comp Neurol. 2004;474:24–42
  66. Bourque CW, Voisin DL, Chakfe Y. Stretch-inactivated cation channels: cellular targets for modulation of osmosensitivity in supraoptic neurons. Prog Brain Res. 2002;139:85–94
  67. Voisin DL, Chakfe Y, Bourque CW. Coincident detection of CSF Na+ and osmotic pressure in osmoregulatory neurons of the supraoptic nucleus. Neuron. 1999;24:453–460
  68. McKinley MJ, Denton DA, Weisinger RS. Sensors for antidiuresis and thirst--osmoreceptors or CSF sodium detectors?. Brain Res. 1978;141:89–103
  69. Chakfe Y, Bourque CW. Excitatory peptides and osmotic pressure modulate mechanosensitive cation channels in concert. Nat Neurosci. 2000;3:572–579
  70. Zhang Z, Bourque CW. Amplification of transducer gain by angiotensin II-mediated enhancement of cortical actin density in osmosensory neurons. J Neurosci. 2008;28:9536–9544
  71. Chakfe Y, Zhang Z, Bourque CW. IL-1beta directly excites isolated rat supraoptic neurons via upregulation of the osmosensory cation current. Am J Physiol Regul Integr Comp Physiol. 2006;290:R1183–R1190
  72. Jorgensen H, Kjaer A, Knigge U, Moller M, Warberg J. Serotonin stimulates hypothalamic mRNA expression and local release of neurohypophysial peptides. J Neuroendocrinol. 2003;15:564–571
  73. Jorgensen H, Riis M, Knigge U, Kjaer A, Warberg J. Serotonin receptors involved in vasopressin and oxytocin secretion. J Neuroendocrinol. 2003;15:242–249
  74. Mikkelsen JD, Hay-Schmidt A, Kiss A. Serotonergic stimulation of the rat hypothalamo-pituitary-adrenal axis: interaction between 5-HT1A and 5-HT2A receptors. Ann N Y Acad Sci. 2004;1018:65–70
  75. Ho SS, Chow BK, Yung WH. Serotonin increases the excitability of the hypothalamic paraventricular nucleus magnocellular neurons. Eur J Neurosci. 2007;25:2991–3000
  76. Jacob S, Spinler SA. Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults. Ann Pharmacother. 2006;40:1618–1622
  77. Stephenson CP, Hunt GE, Topple AN, McGregor IS. The distribution of 3,4-methylenedioxymethamphetamine “Ecstasy”-induced c-fos expression in rat brain. Neuroscience. 1999;92:1011–1023
  78. Fallon JK, Shah D, Kicman AT, et al. Action of MDMA (ecstasy) and its metabolites on arginine vasopressin release. Ann N Y Acad Sci. 2002;965:399–409
  79. Brvar M, Kozelj G, Osredkar J, Mozina M, Gricar M, Bunc M. Polydipsia as another mechanism of hyponatremia after ‘ecstasy’ (3,4 methyldioxymethamphetamine) ingestion. Eur J Emerg Med. 2004;11:302–304
  80. Campbell GA, Rosner MH. The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the kidney. Clin J Am Soc Nephrol. 2008;3:1852–1860
  81. Fraser CL, Arieff AI. Epidemiology, pathophysiology, and management of hyponatremic encephalopathy. Am J Med. 1997;102:67–77
  82. Fraser CL, Arieff AI. Fatal central diabetes mellitus and insipidus resulting from untreated hyponatremia: a new syndrome. Ann Intern Med. 1990;112:113–119
  83. Arieff AI. Influence of hypoxia and sex on hyponatremic encephalopathy. Am J Med. 2006;119:S59–S64
  84. Ayus JC, Arieff AI. Pulmonary complications of hyponatremic encephalopathy (Noncardiogenic pulmonary edema and hypercapnic respiratory failure). Chest. 1995;107:517–521
  85. Soupart A, Penninckx R, Stenuit A, Decaux G. Lack of major hypoxia and significant brain damage in rats despite dramatic hyponatremic encephalopathy. J Lab Clin Med. 1997;130:226–231
  86. Baumann A, Audibert G, McDonnell J, Mertes PM. Neurogenic pulmonary edema. Acta Anaesthesiol Scand. 2007;51:447–455
  87. Ayus JC, Varon J, Arieff AI. Hyponatremia, cerebral edema, and noncardiogenic pulmonary edema in marathon runners. Ann Intern Med. 2000;132:711–714
  88. Siegel AJ, Verbalis JG, Clement S, et al. Hyponatremia in marathon runners due to inappropriate arginine vasopressin secretion. Am J Med. 2007;120:461e11-7
  89. Ellison DH, Berl T. Clinical practice (The syndrome of inappropriate antidiuresis). N Engl J Med. 2007;356:2064–2072
  90. Janicic N, Verbalis JG. Evaluation and management of hypo-osmolality in hospitalized patients. Endocrinol Metab Clin North Am. 2003;32:459–481vii
  91. Nielsen S, Nagelhus EA, Amiry-Moghaddam M, Bourque C, Agre P, Ottersen OP. Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J Neurosci. 1997;17:171–180
  92. Solenov E, Watanabe H, Manley GT, Verkman AS. Sevenfold-reduced osmotic water permeability in primary astrocyte cultures from AQP-4-deficient mice, measured by a fluorescence quenching method. Am J Physiol Cell Physiol. 2004;286:C426–C432
  93. Manley GT, Fujimura M, Ma T, et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med. 2000;6:159–163
  94. Yang B, Zador Z, Verkman AS. Glial cell aquaporin-4 overexpression in transgenic mice accelerates cytotoxic brain swelling. J Biol Chem. 2008;283:15280–15286
  95. Sorani MD, Zador Z, Hurowitz E, Yan D, Giacomini KM, Manley GT. Novel variants in human Aquaporin-4 reduce cellular water permeability. Hum Mol Genet. 2008;17:2379–2389
  96. Papadopoulos MC, Manley GT, Krishna S, Verkman AS. Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. FASEB J. 2004;18:1291–1293
  97. Melton JE, Patlak CS, Pettigrew KD, Cserr HF. Volume regulatory loss of Na, Cl, and K from rat brain during acute hyponatremia. Am J Physiol. 1987;252:F661–F669
  98. Olson JE, Sankar R, Holtzman D, James A, Fleischhacker D. Energy-dependent volume regulation in primary cultured cerebral astrocytes. J Cell Physiol. 1986;128:209–215
  99. Blanz J, Schweizer M, Auberson M, et al. Leukoencephalopathy upon disruption of the chloride channel ClC-2. J Neurosci. 2007;27:6581–6589
  100. Rust MB, Alper SL, Rudhard Y, et al. Disruption of erythroid K-Cl cotransporters alters erythrocyte volume and partially rescues erythrocyte dehydration in SAD mice. J Clin Invest. 2007;117:1708–1717
  101. Boettger T, Rust MB, Maier H, et al. Loss of K-Cl co-transporter KCC3 causes deafness, neurodegeneration and reduced seizure threshold. EMBO J. 2003;22:5422–5434
  102. Howard HC, Mount DB, Rochefort D, et al. The K-Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosum. Nat Genet. 2002;32:384–392
  103. Byun N, Delpire E. Axonal and periaxonal swelling precede peripheral neurodegeneration in KCC3 knockout mice. Neurobiol Dis. 2007;28:39–51
  104. Ringel F, Plesnila N. Expression and functional role of potassium-chloride cotransporters (KCC) in astrocytes and C6 glioma cells. Neurosci Lett. 2008;442:219–223
  105. Lenertz LY, Lee BH, Min X, et al. Properties of WNK1 and implications for other family members. J Biol Chem. 2005;280:26653–26658
  106. Kahle KT, Ring AM, Lifton RP. Molecular physiology of the WNK kinases. Annu Rev Physiol. 2008;70:329–355
  107. Moriguchi T, Urushiyama S, Hisamoto N, et al. WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1. J Biol Chem. 2005;280:42685–42693
  108. Vitari AC, Thastrup J, Rafiqi FH, et al. Functional interactions of the SPAK/OSR1 kinases with their upstream activator WNK1 and downstream substrate NKCC1. Biochem J. 2006;397:223–231
  109. Gagnon KB, England R, Delpire E. Characterization of SPAK and OSR1, regulatory kinases of the Na-K-2Cl cotransporter. Mol Cell Biol. 2006;26:689–698
  110. Falin RA, Morrison R, Ham AJ, Strange K. Identification of regulatory phosphorylation sites in a cell volume- and Ste20 kinase-dependent ClC anion channel. J Gen Physiol. 2009;133:29–42
  111. Videen JS, Michaelis T, Pinto P, Ross BD. Human cerebral osmolytes during chronic hyponatremia (A proton magnetic resonance spectroscopy study). J Clin Invest. 1995;95:788–793
  112. Ayus JC, Armstrong D, Arieff AI. Hyponatremia with hypoxia: effects on brain adaptation, perfusion, and histology in rodents. Kidney Int. 2006;69:1319–1325
  113. Gocht A, Colmant HJ. Central pontine and extrapontine myelinolysis: a report of 58 cases. Clin Neuropathol. 1987;6:262–270
  114. Martin RJ. Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. J Neurol Neurosurg Psychiatry. 2004;75(Suppl 3):iii22–iii28
  115. Verbalis JG, Martinez AJ. Neurological and neuropathological sequelae of correction of chronic hyponatremia. Kidney Int. 1991;39:1274–1282
  116. Laureno R. Central pontine myelinolysis following rapid correction of hyponatremia. Ann Neurol. 1983;13:232–242
  117. Soupart A, Penninckx R, Crenier L, Stenuit A, Perier O, Decaux G. Prevention of brain demyelination in rats after excessive correction of chronic hyponatremia by serum sodium lowering. Kidney Int. 1994;45:193–200
  118. Verbalis JG, Gullans SR. Rapid correction of hyponatremia produces differential effects on brain osmolyte and electrolyte reaccumulation in rats. Brain Res. 1993;606:19–27
  119. Lien YH, Shapiro JI, Chan L. Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia (Implications for the pathogenesis of central pontine myelinolysis). J Clin Invest. 1991;88:303–309
  120. Sterns RH, Thomas DJ, Herndon RM. Brain dehydration and neurologic deterioration after rapid correction of hyponatremia. Kidney Int. 1989;35:69–75
  121. Lien YH. Role of organic osmolytes in myelinolysis (A topographic study in rats after rapid correction of hyponatremia). J Clin Invest. 1995;95:1579–1586
  122. Silver SM, Schroeder BM, Sterns RH. Brain uptake of myoinositol after exogenous administration. J Am Soc Nephrol. 2002;13:1255–1260
  123. Silver SM, Schroeder BM, Sterns RH, Rojiani AM. Myoinositol administration improves survival and reduces myelinolysis after rapid correction of chronic hyponatremia in rats. J Neuropathol Exp Neurol. 2006;65:37–44
  124. DeLuca GC, Nagy Z, Esiri MM, Davey P. Evidence for a role for apoptosis in central pontine myelinolysis. Acta Neuropathol. 2002;103:590–598
  125. Alfieri RR, Cavazzoni A, Petronini PG, et al. Compatible osmolytes modulate the response of porcine endothelial cells to hypertonicity and protect them from apoptosis. J Physiol. 2002;540:499–508
  126. Maallem S, Mutin M, Gonzalez-Gonzalez IM, Zafra F, Tappaz ML. Selective tonicity-induced expression of the neutral amino-acid transporter SNAT2 in oligodendrocytes in rat brain following systemic hypertonicity. Neuroscience. 2008;153:95–107
  127. Adler S, Verbalis JG, Williams D. Effect of rapid correction of hyponatremia on the blood-brain barrier of rats. Brain Res. 1995;679:135–143
  128. Adler S, Martinez J, Williams DS, Verbalis JG. Positive association between blood brain barrier disruption and osmotically-induced demyelination. Mult Scler. 2000;6:24–31
  129. Baker EA, Tian Y, Adler S, Verbalis JG. Blood-brain barrier disruption and complement activation in the brain following rapid correction of chronic hyponatremia. Exp Neurol. 2000;165:221–230
  130. Sugimura Y, Murase T, Takefuji S, et al. Protective effect of dexamethasone on osmotic-induced demyelination in rats. Exp Neurol. 2005;192:178–183
  131. Perianayagam A, Sterns RH, Silver SM, et al. DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia. Clin J Am Soc Nephrol. 2008;3:331–336
  132. Oya S, Tsutsumi K, Ueki K, Kirino T. Reinduction of hyponatremia to treat central pontine myelinolysis. Neurology. 2001;57:1931–1932
  133. Qi X, Inagaki K, Sobel RA, Mochly-Rosen D. Sustained pharmacological inhibition of deltaPKC protects against hypertensive encephalopathy through prevention of blood-brain barrier breakdown in rats. J Clin Invest. 2008;118:173–182
  134. Robertson GL, Shelton RL, Athar S. The osmoregulation of vasopressin. Kidney Int. 1976;10:25–37

 Supported by National Institutes of Health grants (DK57708 and DK070756), the American Heart Association, and the Veterans Administration.

PII: S0270-9295(09)00058-8

doi: 10.1016/j.semnephrol.2009.03.021

Seminars in Nephrology
Volume 29, Issue 3 , Pages 196-215 , May 2009

Article Tools

* Image Usage & Resolution